Method for determining immune system affecting compounds
United States Patent Application 20050153329
Kind Code A1
Hakansson, Leif ; et al. July 14, 2005
Method for determining immune system affecting compounds
Abstract
The present invention relates to a method for increasing efficacy and/or possibility of therapeutic treatment of cancer, wherein any dys-regulatory mechanism, including inducing factor/s, of the production of immunoregulatory substances, including one or more cytokines, including IL-1.beta., IL-1Ra, IL-6, IL-10, IL-17, TNF-.alpha., and others, is therapeutically controlled to minimise pathological production of such immunoregulatory substances, to enhance the therapeutic control of a malignant tumour in a subject suffering from a cancer, a method for analysing dys-regulatory mechanism controlling substances, kit for such analysis, use of certain compounds for preparing pharmaceutical preparations, and pharmaceutical preparations.
Inventors: Hakansson, Leif; (Vikingstad, SE) ; Hakansson, Annika; (Vikingstad, SE) ; Clinchy, Birgitta; (Ljungsbro, SE)
Correspondence Name and Address: YOUNG & THOMPSON
745 SOUTH 23RD STREET
2ND FLOOR
ARLINGTON
VA
22202
US
Serial No.: 997985
Series Code: 10
Filed: November 29, 2004
U.S. Current Class: 435/6; 435/7.23
U.S. Class at Publication: 435/006; 435/007.23
Intern'l Class: C12Q 001/68; G01N 033/574
Comments: 0
Votes:17